Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

about

Nonobese, Nonketotic Childhood-Onset Diabetes: Look for Lipodystrophies.

P2860

Q50131232-89FD6CD7-400F-43F6-922E-30189A450C9A

P2860

Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

Item

http://www.wikidata.org/entity/Q47821479

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

@en

Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

@nl

type

Item

label

Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

@en

Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

@nl

prefLabel

Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

@en

Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

@nl

P1476

Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

@en

P2093

Cristina Adelia Meehan

http://www.w3.org/2001/XMLSchema#string

David E Kleiner

http://www.w3.org/2001/XMLSchema#string

Elaine Cochran

http://www.w3.org/2001/XMLSchema#string

Kristina I Rother

http://www.w3.org/2001/XMLSchema#string

Mary Walter

http://www.w3.org/2001/XMLSchema#string

Phillip Gorden

http://www.w3.org/2001/XMLSchema#string

Rebecca J Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical review#: Lipodystrophies: genetic and acquired body fat disorders

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy.

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.

Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation.

Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature.

Metabolic control of puberty: roles of leptin and kisspeptins.

Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy.

Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin.

P304

1511-1519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2016-3628

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28324110

http://www.w3.org/2001/XMLSchema#string

P932

5443330

http://www.w3.org/2001/XMLSchema#string

Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

about

P2860

P2860

Effects of Metreleptin in Pediatric Patients With Lipodystrophy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932